Contact us on +44 (0)1270 270010 | info@boydconsultants.com

WEBINAR RECORDING: Early drug development – key considerations to maximise success

WEBINAR RECORDING: Early drug development – key considerations to maximise success
July 22, 2020 SueCarr

Boyds hosted an online workshop focusing on early drug development on the 16 July.

Members of the Boyds Consulting Team took delegates through early drug development activities, which can often be complex, and explained the do’s and don’ts when planning a CTA/IND-enabling programme. The team focused on aligning development and regulatory activities and the importance of integrated development plans, helping achieve accelerated development.

Webinar recordings

Clip one: Non-clinical development programmes to support first-in-human studies
Clip two: Integrated development planning
Clip three: Preparing clinical trial applications 
Clip four: Orphan drug designations and accelerated access 

Q&A and slides

During the webinar, delegates were able to post questions to the panel. These have now been collated and can be viewed here with the responses.

A full copy of the slides is available here.

For more information on the services from Boyds and to find out how we can help you with your drug development activities, click here or get in touch with a member of the team today.